CHAIRMAN'S LETTER

ABSTRACT

Robert Malone, an mRNA researcher, appeared on television recently, expressing strong concern over the risk-benefit analysis of vaccination for young adults (3), and the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recently met to discuss instances of myocarditis or pericarditis in people aged 30 and younger who have received an mRNA COVID-19 vaccine. What we do know for certain is that the incredible strength and collaboration of the scientific community have allowed us to regain some semblance of normalcy. The development and rollout of multiple effective vaccine options have been the medical miracle of our lifetime.